Track NovaBay Pharmaceuticals, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

NovaBay Pharmaceuticals, Inc. NBY · Stock Open NovaBay Pharmaceuticals, Inc. in new tab

1.47 USD
P/E
0.05
EPS
-28.50
Yield
272.13%
Safety Score
45
P/B
-2.12
ROE
-516.26
Beta
0.16
Target Price
3.73 USD
Loading chart...
Key Metrics
Earnings dateApril 1, 2026
P/E0.05
EPS-28.50
Book Value-0.92
Price to Book-2.12
Debt/Equity59.36
% Insiders90.143%
Growth
Revenue Growth-0.79%
Estimates
Forward P/E-2.38
Forward EPS-0.82
Target Mean Price3.73
Dividend
Dividend Yield272.13%
Annual dividends4.00 USD
Ex-Div. DateSept. 30, 2025
Payout1.00%

DCF valuation

Model fair value for NovaBay Pharmaceuticals, Inc. (NBY)
Result
Sign in to run the valuation for NBY.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 3.73 USD (low 0.85, high 6.60)
Low 0.85
Mean 3.73
High 6.60
Price 1.47
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

NovaBay Pharmaceuticals, Inc. Logo NovaBay Pharmaceuticals, Inc. Analysis (NBY)

United States Health Care Official Website Stock

Is NovaBay Pharmaceuticals, Inc. a good investment? NovaBay Pharmaceuticals, Inc. (NBY) is currently trading at 1.47 USD. Market analysts have a consensus price target of 3.73 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 0.05. This relatively low multiple may signal that NovaBay Pharmaceuticals, Inc. is undervalued compared to historical market norms.

Earnings Schedule: NovaBay Pharmaceuticals, Inc. is expected to release its next earnings report on April 1, 2026. The market consensus estimate for Forward EPS is -0.82.

For income investors, NovaBay Pharmaceuticals, Inc. pays a dividend yield of 272.13%. With a payout ratio of 1%, the dividend appears sustainable.

Investor FAQ

Does NovaBay Pharmaceuticals, Inc. pay a dividend?

Yes, it pays an annual dividend of 4.00 USD (272.13% yield).

What asset class is NovaBay Pharmaceuticals, Inc.?

NovaBay Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be April 1, 2026. The company currently has a trailing EPS of -28.50.

Company Profile

NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Exchange Ticker
ASE (United States) NBY
Trades
Dividend Yield
272.13%
Annual Dividends
4.00USD
Next Ex. Div Date
Sept. 30, 2025
Payout Ratio
1.00%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2025
0.80 USD
Sept. 30, 2025 0.8000
Stock Splits
Split Date Split Ratio to 1
Dec. 18, 2015 1:25
Nov. 16, 2022 0.03
May 31, 2024 0.03
Feb. 23, 2026 1:5
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion